Serna Bio
Pre-clinicalSerna Bio uses AI and data to explore RNA-small molecule interactions, developing innovative therapies for undruggable proteins and non-coding RNA targets.
Founded
2021
Focus
Small Molecules
About
Serna Bio uses AI and data to explore RNA-small molecule interactions, developing innovative therapies for undruggable proteins and non-coding RNA targets.
Funding History
2Total raised: $34.5M
Series A$30MKhosla VenturesOct 15, 2023
Seed$4.5MAhren Innovation CapitalMar 15, 2022
Company Info
TypePrivate
Founded2021
LocationLondon, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile